Impact of Pharmacist Board Certification on Health Outcomes of Critically Ill Patients: An Analysis of the Optimizing Pharmacist-Team Integration for ICU Patient Management (OPTIM) Study.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος:	Impact of Pharmacist Board Certification on Health Outcomes of Critically Ill Patients: An Analysis of the Optimizing Pharmacist-Team Integration for ICU Patient Management (OPTIM) Study.
Συγγραφείς:	Smith SE; College of Pharmacy, University of Georgia, Athens, Georgia, USA., Henry K; School of Medicine, University of Colorado, Aurora, Colorado, USA., Heavner MS; School of Pharmacy, University of Maryland, Baltimore, Maryland, USA., Keedy C; College of Pharmacy, University of Georgia, Savannah, Georgia, USA., Duong H; College of Pharmacy, University of Georgia, Athens, Georgia, USA., Chen Z; College of Public Health, University of Georgia, Athens, Georgia, USA., Chen X; College of Public Health, University of Georgia, Athens, Georgia, USA., Sikora A; School of Medicine, University of Colorado, Aurora, Colorado, USA.
Συλλογικό Έργο:	OPTIM Investigator Team
Πηγή:	Journal of the American College of Clinical Pharmacy : JACCP [J Am Coll Clin Pharm] 2026 Jul; Vol. 9 (7), pp. e70258.
Τύπος έκδοσης:	Journal Article; Multicenter Study; Observational Study
Γλώσσα:	English
Στοιχεία περιοδικού:	Publisher: Wiley Country of Publication: United States NLM ID: 101723133 Publication Model: Print Cited Medium: Internet ISSN: 2574-9870 (Electronic) Linking ISSN: 25749870 NLM ISO Abbreviation: J Am Coll Clin Pharm Subsets: MEDLINE
Imprint Name(s):	Original Publication: [Hoboken, NJ] : Wiley, [2018]-
Ιατρικοί όροι (MeSH):	Pharmacists/standards , Pharmacists/organization & administration , Intensive Care Units/organization & administration , Intensive Care Units/standards , Critical Illness/therapy , Critical Illness/mortality , Certification/standards , Pharmacy Service, Hospital/standards , Pharmacy Service, Hospital/organization & administration , Patient Care Team/standards , Patient Care Team/organization & administration , Critical Care/standards, Humans ; Female ; Hospital Mortality ; Male ; Middle Aged ; Aged ; Workload ; Professional Role
Περίληψη:	Background: Critical care pharmacists (CCPs) reduce adverse drug events (ADEs) and mortality in the intensive care unit (ICU). Board certification is the established professional standard for CCPs, but its impact on ICU patient outcomes, including its relationship between CCP characteristics and workload, remains unclear. The purpose of this study was to evaluate the association between pharmacist board certification, CCP workload characteristics, and patient outcomes. Methods: This was a pre-planned analysis of the multicenter, observational Optimizing Pharmacist-Team Integration for ICU Patient Management (OPTIM) study including adult ICU patients cared for by CCPs. Patients cared for exclusively by board-certified pharmacists on every ICU day were categorized as the BCP group; those with at least 1 day of care from a non-board-certified pharmacist comprised the non-BCP group. The primary outcome was hospital mortality; secondary outcomes included the hazard of discharge alive (HDA) from the ICU and hospital. Multivariable logistic regression was used to evaluate the association between BCP and mortality; Fine-Gray competing risk models were used to assess the relationship between BCP and ICU and hospital HDA. Results: In total, 201 pharmacists (184 BCPs; 17 non-BCPs) from 63 institutions caring for 20 537 ICU patients were included. Care provided exclusively by a BCP (vs ≥ 1 day by a non-BCP) was associated with lower mortality (odds ratio [OR] 0.80, 95% confidence interval [CI] 0.69-0.92, p = 0.002) and both a higher ICU HDA (hazard ratio [HR] 1.08, 95% CI 1.03-1.13, p < 0.001) and hospital HDA (HR 1.19, 95% CI 1.13-1.26, p < 0.001). Conclusion: Daily ICU care delivered by pharmacists with board certification was independently associated with reduced mortality and improved HDA from the ICU. Board-certified pharmacists may enhance the quality and/or efficiency of critical care pharmacy services. These findings support the role of board certification as a modifiable factor to improve patient outcomes and optimize workload in the ICU. (© 2026 The Author(s). JACCP: Journal of the American College of Clinical Pharmacy published by Wiley Periodicals LLC on behalf of ACCP Foundation, Ltd.)
References:	I. Lat, C. Paciullo, M. J. Daley, et al., “Position Paper on Critical Care Pharmacy Services (Executive Summary): 2020 Update,” Critical Care Medicine 48, no. 9 (2020): 1375–1382, https://doi.org/10.1097/CCM.0000000000004438. L. L. Leape, D. J. Cullen, M. D. Clapp, et al., “Pharmacist Participation on Physician Rounds and Adverse Drug Events in the Intensive Care Unit,” JAMA 282, no. 3 (1999): 267–270, https://doi.org/10.1001/jama.282.3.267. Global Patient Safety Action Plan 2021–2030 (World Health Organization, 2021). P. Aspden, J. A. Wolcott, J. L. Bootman, and L. R. Cronenwett, Preventing Medication Errors (National Academies Press, 2007). A. S. Newsome, S. E. Smith, T. W. Jones, A. Taylor, M. A. Van Berkel, and M. Rabinovich, “A Survey of Critical Care Pharmacists to Patient Ratios and Practice Characteristics in Intensive Care Units,” Journal of the American College of Clinical Pharmacy 3, no. 1 (2019): 68–74. R. MacLaren, R. J. Roberts, A. L. Dzierba, M. Buckley, I. Lat, and S. W. Lam, “Characterizing Critical Care Pharmacy Services Across the United States,” Critical Care Explorations 3, no. 1 (2021): e0323, https://doi.org/10.1097/CCE.0000000000000323. C. A. Pedersen, P. J. Schneider, M. C. Ganio, and D. J. Scheckelhoff, “ASHP National Survey of Pharmacy Practice in Hospital Settings: Monitoring and Patient Education‐2018,” American Journal of Health‐System Pharmacy 76, no. 14 (2019): 1038–1058, https://doi.org/10.1093/ajhp/zxz099. N. Embriaco, L. Papazian, N. Kentish‐Barnes, F. Pochard, and E. Azoulay, “Burnout Syndrome Among Critical Care Healthcare Workers,” Current Opinion in Critical Care 13, no. 5 (2007): 482–488, https://doi.org/10.1097/MCC.0b013e3282efd28a. S. E. Smith, A. A. Slaughter, S. A. Butler, M. S. Buckley, R. MacLaren, and A. S. Newsome, “Examination of Critical Care Pharmacist Work Activities and Burnout. JACCP: Journal of the American College of,” Clinical Pharmacy 4, no. 5 (2021): 554–569. C. H. Chuang, P. C. Tseng, C. Y. Lin, K. H. Lin, and Y. Y. Chen, “Burnout in the Intensive Care Unit Professionals: A Systematic Review,” Medicine (Baltimore) 95, no. 50 (2016): e5629, https://doi.org/10.1097/MD.0000000000005629. Critical Care Pharmacy Certification (BCCCP) (Board of Pharmacy Specialties, 2026). S. Suzuki, H. Sakurai, K. Kawasumi, M. Tahara, S. Saito, and K. Endo, “The Impact of Pharmacist Certification on the Quality of Chemotherapy in Japan,” International Journal of Clinical Pharmacy 38, no. 5 (2016): 1326–1335, https://doi.org/10.1007/s11096‐016‐0374‐6. M. P. Dorsch, J. M. Lose, and R. J. DiDomenico, “The Effect of Cardiovascular Credentialed Pharmacists on Process Measures and Outcomes in Myocardial Infarction and Heart Failure,” Pharmacotherapy 34, no. 8 (2014): 803–808, https://doi.org/10.1002/phar.1444. S. Smith, K. Henry, M. Heavner, et al., “Optimization of Pharmacist Medication Management and Mortality in the Intensive Care Unit,” medRxiv (2026), https://doi.org/10.64898/2025.12.31.25342855. “REDCap Research Electronic Data Capture,” https://projectredcap.org/about/. World Medical Association, “World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects,” Journal of the American Medical Association 310, no. 20 (2013): 2191–2194, https://doi.org/10.1001/jama.2013.281053. ASHP, “Comprehensive Medication Management: promoting optimized and personalized use of medication through comprehensive medication management,” https://www.ashp.org/advocacy‐and‐issues/key‐issues/other‐issues/comprehensive‐medication‐management?loginreturnUrl=SSOCheckOnly. A. J. Webb, S. Rowe, and A. S. Newsome, “A Descriptive Report of the Rapid Implementation of Automated MRC‐ICU Calculations in the EMR of an Academic Medical Center,” American Journal of Health‐System Pharmacy 79, no. 12 (2022): 979–983, https://doi.org/10.1093/ajhp/zxac059. A. A. E. Elmdni, “The Impact of Nurse‐Patient Ratios on Patient Outcomes in Intensive Care Units,” Nursing in Critical Care 30, no. 3 (2025): e70054, https://doi.org/10.1111/nicc.70054. R. J. DiDomenico , S. E. Smith, A. Chan, et al., “A Roadmap for Studying the Impact of Pharmacist Board Certification on Patient Outcomes: Feasibility, Applicability, and Methodological Considerations,” Journal of the American College of Clinical Pharmacy 9, no. 2 (2026): e70165, https://doi.org/10.1002/jac5.70165.
Grant Information:	R21HS028485 United States HS AHRQ HHS; R01HS029009 United States HS AHRQ HHS; University of Maryland, Baltimore; ASHP Research and Education Foundation; Board of Pharmacy Specialties; ACCP Critical Care PRN; UL1TR002378 United States TR NCATS NIH HHS
Contributed Indexing:	Investigator: SAH Adams; S Adie; MO Agunsoye; M Alanazi; AM Alhammad; E Alkurdi; SJ Allcron; CA Anderson; WS Anderson; E Anderson; KL Artman; WB Awad; LD Banuelos; AT Basting; J Bauer; K Beach; E Beauclair; A Becker; RM Belcher; A Bernarde; KL Birrer; CJ Bollinger; AN Boyd; TN Branan; JM Brochu; M Brownstein; QV Bui; M Burden; SO Butler; SL Campbell-Bright; CL Candeloro; I Capistrano; BL Carter; GL Casal; AM Castillo; AM Chase; J Chestnutt; SRL Ciapala; AM Clark; KA Connor; JM Connor; JM Corvelli; E Covington; JF Cox; SN Daniel-McCalla; H Davis; AA Defayette; JW Devlin; TN DiGiacomo; SA Dine; SD Kochheiser; CR Dodson; KL Doerhoff; C Dominick; LJ Doriety; S Dunham; K Dvoracek; E Dye; ME Feeney; CC Forehand; NS Fox; AD Fraley; K Giang; CD Gresham; K Griebe; R Grimes; A Haber; RA Halabi; RA Hall; CD Hauser; A Hawthorne; TL Hedrick; B Herrmann; MJ Hodges; AK Holliman; C Hoover; E Houry; J Hu; WT Huang; NE Hume; KR Humphreys; M Ingebrigtson; S Janusz; K Jimison; KE John; SR Jones; N Kaltakdjian; LC Kennedy; R Kessinger; A Killian; NS Kong; CL Kressin; CE Kroll; AM Kurtz; MC Lail; KM Landolf; E Lee; JS Lee; K Leon; M Li; MJ Lin; N Lu; WJ Ly; KL Madding; O Marchionda; A Marques; GS Martin; WG Mays; BL McDaniel; AM McIntire; BP McKinzie; M McNeely; AS Meester; A Mendoza; K Meyer; AE Milkovits; JT Miller; C Miller; KL Mills; C Murphy; DJ Murphy; B Murray; ND Naik; LH Nazer; AM Nei; J Netley; JD Nguyen; CC Nicolosi; NM Palm; KA Pandya; KA Parbouni; SE Parli; S Patel; AS Patel; K Petrucci; B Phan; ST Proctor; SH Rappaport; M Ray; P Reese; SL Rhoades; T Robinson; C Rojas; KM Ryman; AJ Sacco; MN Saling; RA Sbertoli; MA Scarbrough; AE Schoening; J Shin; ZR Smith; BA Smith; B Smith; M Smith; A Sonchaiwanich; K Spezzano; G Steiger; DA Steinbacher; JA Stoldt; MA Street; MK Stubbs; J Tawwater; AN Taylor; D Taylor; T Thompson; KA Toews; TT Tran; A Tyson; SA Valencia; M Vallabh; SA Van Wey; BE Varnes; VC Velazco; AJ Vidger; D Vo; A Vu; SC Waldrep; JA Ward; NB Wayne; L Wetmore; JA Whitten; AM Wiegand; SK Williford; S Wilson; KM Wohlfarth; DR Wylie; SYA Yeung; JH Yook; CH Yoon Keywords: certification; critical care; length of stay; mortality; patient; pharmacists; workload
Entry Date(s):	Date Created: 20260708 Date Completed: 20260708 Latest Revision: 20260728
Update Code:	20260728
DOI:	10.1002/jac5.70258
PMID:	42415307
Βάση Δεδομένων:	MEDLINE

Full Text Finder

Περιγραφή
ISSN:	2574-9870
DOI:	10.1002/jac5.70258